Manuela Gambella, Alberto Rocci, Roberto Passera, Francesca Gay, Paola Omedè, Claudia Crippa, Paolo Corradini, Alessandra Romano, Davide Rossi, Marco Ladetto, Mario Boccadoro, Antonio Palumbo. High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. Haematologica 2014;99(2):e14-e16; https://doi.org/10.3324/haematol.2013.090142.